Except for NF2, for which missense mutations have been discovered in 1.9% and 5.3% of human HCC and ICC cases, respectively [12], somatic or germline mutations in neither MST1/2 nor LATS1/2 genes have been reported in common cancers [14]. Here, MST1 is linked to intrahepatic cholangiocarcinoma.